Login / Signup

Safety and Pharmacokinetics of HTL0018318, a Novel M1 Receptor Agonist, Given in Combination with Donepezil at Steady State: A Randomized Trial in Healthy Elderly Subjects.

Charlotte BakkerJasper van der AartGeert LabotsJan LiptrotDavid M CrossErica S KlaassenSteve DickinsonTim TaskerGeert Jan Groeneveld
Published in: Drugs in R&D (2021)
Netherlands Trial register identifier NL5915, registered on 28 October 2016.
Keyphrases
  • phase iii
  • study protocol
  • middle aged
  • phase ii
  • clinical trial
  • community dwelling
  • randomized controlled trial
  • open label